What labs and studies should be ordered for a 70-year-old woman with mild anemia (hemoglobin 11.8 g/dL, hematocrit 35.2 %) and normal aspartate aminotransferase?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Mild Anemia in a 70-Year-Old Female

Order a complete iron panel (serum ferritin, transferrin saturation, serum iron, and total iron-binding capacity) together with C-reactive protein, vitamin B12, folate, and a reticulocyte count to evaluate this mild anemia. 1, 2

Initial Laboratory Assessment

The patient meets criteria for mild anemia with hemoglobin 11.8 g/dL (threshold <12.0 g/dL for women) and hematocrit 35.2% 1. The normal AST of 11 IU/L effectively excludes liver disease as a contributing cause 3, 4.

Essential Iron Studies

Iron status evaluation is the cornerstone of anemia workup and must include:

  • Serum ferritin – Values <30 µg/L confirm depleted iron stores when inflammation is absent and represent the single most reliable marker for iron deficiency 1, 2
  • Transferrin saturation – Levels <15-16% support iron deficiency and are less affected by acute inflammation than ferritin, helping differentiate from anemia of chronic disease 1, 2
  • C-reactive protein (CRP) – Must be measured concurrently because ferritin rises as an acute-phase reactant; a normal CRP is required to interpret low ferritin accurately 1, 2

Additional Required Tests

  • Vitamin B12 and folate levels – Deficiencies cause macrocytic anemia but can coexist with iron deficiency 1, 5
  • Reticulocyte count – A low or inappropriately normal reticulocyte response suggests inadequate bone marrow compensation, consistent with iron deficiency or other production defects 1
  • Complete blood count with differential – Evaluates mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and red cell distribution width (RDW) to characterize the anemia 1

Clinical Significance in Older Adults

Even mild anemia at this level carries substantial clinical consequences. Hemoglobin of 11.8 g/dL is associated with increased risk of hospitalization (adjusted hazard ratio 1.32) and mortality (adjusted hazard ratio 1.86) in elderly populations 6. Mobility difficulty prevalence is significantly higher at hemoglobin 12.0 g/dL compared to 13.5 g/dL, even after adjusting for chronic diseases 7.

Common Etiologies in This Age Group

Approximately one-third of anemia in older adults stems from nutritional deficiency (iron, B12, folate), one-third from chronic inflammation or chronic kidney disease, and one-third remains unexplained after initial evaluation 8. Given the patient's age of 70 years, standard anemia definitions may not fully apply, as hemoglobin thresholds can vary in this population 1.

Critical Diagnostic Pitfalls to Avoid

  • Do not rely on ferritin alone without CRP – Inflammation falsely elevates ferritin and masks true iron deficiency 2
  • Do not assume normal MCV excludes iron deficiency – MCH typically falls before MCV in early deficiency 2
  • Do not limit evaluation to CBC alone – Full iron studies are required for proper diagnosis per WHO criteria 2

Investigation for Underlying Cause

If iron deficiency is confirmed, gastrointestinal evaluation is warranted in this age group. Iron deficiency anemia in older adults often results from occult gastrointestinal bleeding, and endoscopy should be considered to evaluate for malignancy 5, 8. In postmenopausal women, menstrual losses are not a factor, making GI sources more likely 2.

Follow-Up Assessment

Re-measure hemoglobin at 4 weeks if empiric iron therapy is initiated. An increase of ≥1 g/dL confirms iron-deficiency anemia and validates continuation of therapy for an additional 3 months to replenish stores 2. If no hematologic response occurs despite documented adherence, consider hemoglobin electrophoresis to exclude thalassemia trait and evaluate for other causes including myelodysplastic syndrome 2, 5, 8.

Related Questions

What workup is recommended for a 75-year-old male with chronic anemia (low hemoglobin)?
What is the best course of action for a bedbound, G-tube (gastrostomy tube) fed, likely elderly patient with significant underlying medical conditions, experiencing a notable decline in hemoglobin from 9.6 to 7.8 over 9 months?
What are the common causes of anemia in the elderly?
In a 57-year-old woman with normal hemoglobin and hematocrit, low mean corpuscular hemoglobin concentration, elevated platelet count (thrombocytosis), and normal iron studies, what is the likely cause and how should she be managed?
How to manage anemia in a 70-year-old male on statin (HMG-CoA reductase inhibitor) with low hemoglobin and hematocrit levels?
What is the recommended first‑line management of acute epididymitis in a sexually active male, specifying antibiotic regimens for patients younger than 35 years versus those older than 35 years, along with supportive measures and follow‑up recommendations?
What is the recommended management for a healthy adult with mild‑to‑moderate traveler’s diarrhea (≤ three unformed stools in 24 hours, no fever, no blood, and no severe abdominal pain)?
What is the appropriate duration of rifaximin therapy for a small intestinal bacterial overgrowth (SIBO) flare?
Does the shingles vaccine (recombinant zoster vaccine Shingrix or live‑attenuated Zostavax) help prevent or reduce herpes simplex virus (HSV‑1 or HSV‑2) outbreaks?
In an immunocompromised patient taking valganciclovir (Valcyte) for cytomegalovirus prophylaxis who now has shingles without blisters (zoster sine herpete), should I continue the valganciclovir?
In a 69-year-old woman taking escitalopram 20 mg daily who has newly detected premature ventricular contractions but is asymptomatic, what is the appropriate management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.